Conduit Pharmaceuticals (CDT) Insider Trading & Ownership $0.10 +0.01 (+10.85%) (As of 11/21/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Conduit Pharmaceuticals (NASDAQ:CDT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage34.74%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.45 M Get CDT Insider Trade Alerts Want to know when executives and insiders are buying or selling Conduit Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CDT Insider Buying and Selling by Quarter Ad InvestorPlaceWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.Click here now to watch the full briefing and discover the steps to take today. Conduit Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/7/2024Ltd NirlandMajor ShareholderSell939,009$0.10$93,900.90 10/4/2024Ltd NirlandMajor ShareholderSell1,368,991$0.10$136,899.10 10/2/2024Ltd NirlandMajor ShareholderSell333,177$0.10$33,317.70 9/30/2024Ltd NirlandMajor ShareholderSell1,016,823$0.12$122,018.76 7/17/2024Andrew ReganDirectorSell1,514,100$0.26$393,666.00 7/15/2024Andrew ReganDirectorSell1,005,200$0.25$251,300.00 What Comes Next Could Be a Once-in-a-Lifetime Opportunity (Ad)A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.Click here now to watch the full briefing and discover the steps to take today.7/12/2024Andrew ReganDirectorSell1,389,820$0.25$347,455.00 7/10/2024Andrew ReganDirectorSell150,000$0.33$49,500.00 7/8/2024Andrew ReganDirectorSell35,923$0.51$18,320.73 7/3/2024Andrew ReganDirectorSell1,000$0.64$640.00 (Data available from 1/1/2013 forward) CDT Insider Trading Activity - Frequently Asked Questions Who is on Conduit Pharmaceuticals's Insider Roster? The list of insiders at Conduit Pharmaceuticals includes Andrew Regan, and Ltd Nirland. Learn more on insiders at CDT. What percentage of Conduit Pharmaceuticals stock is owned by insiders? 34.74% of Conduit Pharmaceuticals stock is owned by insiders. Learn more on CDT's insider holdings. Which Conduit Pharmaceuticals insiders have been selling company stock? The following insiders have sold CDT shares in the last 24 months: Andrew Regan ($1,060,881.73), and Ltd Nirland ($386,136.46). How much insider selling is happening at Conduit Pharmaceuticals? Insiders have sold a total of 7,754,043 Conduit Pharmaceuticals shares in the last 24 months for a total of $1,447,018.19 sold. Conduit Pharmaceuticals Key ExecutivesDr. David Joszef Tapolczay (Age 65)CEO & Director Compensation: $419.8kMr. Adam Sragovicz (Age 54)Chief Financial Officer Compensation: $116.67kDr. Joanne M. Holland (Age 49)Chief Scientific Officer More Insider Trading Tools from MarketBeat Related Companies Anebulo Pharmaceuticals Insider Selling CEL-SCI Insider Selling Lumos Pharma Insider Selling CERo Therapeutics Insider Selling OKYO Pharma Insider Selling RAPT Therapeutics Insider Selling Elevation Oncology Insider Selling Lexaria Bioscience Insider Selling Clene Insider Selling Passage Bio Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CDT) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Conduit Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDT Stock Alerts